These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 552099)

  • 1. Differential regulation of the formation of prostaglandins and related substances from arachidonic acid and from dihomogammalinolenic acid. I. Effects of ethanol.
    Manku MS; Oka M; Horrobin DF
    Prostaglandins Med; 1979 Aug; 3(2):119-28. PubMed ID: 552099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of the formation of prostaglandins and related substances from arachidonic acid and from dihomogammalinolenic acid. II. Effects of vitamin C.
    Manku MS; Oka M; Horrobin DF
    Prostaglandins Med; 1979 Aug; 3(2):129-37. PubMed ID: 552100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human platelet PGE1 and dihomogammalinolenic acid. Comparison to PGE2 and arachidonic acid.
    Lagarde M; Guichardant M; Dechavanne M
    Prog Lipid Res; 1981; 20():439-43. PubMed ID: 6804973
    [No Abstract]   [Full Text] [Related]  

  • 4. Precursor- and pool-dependent differential effects of ethanol on human platelet prostanoid synthesis.
    Segarnick DJ; Ryer H; Rotrosen J
    Biochem Pharmacol; 1985 Apr; 34(8):1343-6. PubMed ID: 3922375
    [No Abstract]   [Full Text] [Related]  

  • 5. Interactions between prostaglandin precursors during their oxygenation by human platelets.
    Boukhchache D; Lagarde M
    Biochim Biophys Acta; 1982 Nov; 713(2):386-92. PubMed ID: 6295499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of arachidonic acid by macaque platelets. Implications for studies on atherosclerosis.
    Beatty CH; Howard CF; Hoskins MK; Herrington PT
    Atherosclerosis; 1985 Apr; 55(1):1-13. PubMed ID: 3924062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformations of exogenous arachidonic acid in human platelets in the presence of oleic- and eicosapentaenoic acids.
    Srivastava KC
    Prostaglandins Leukot Med; 1985 Apr; 18(1):31-7. PubMed ID: 2987977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of arachidonic acid by platelets: utilization of arachidonic acid by human platelets in presence of linoleic and dihomo-gamma-linolenic acids.
    Srivastava KC
    Z Ernahrungswiss; 1978 Dec; 17(4):248-61. PubMed ID: 32674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet aggregation and thromboxane production by pinacidil.
    Goodman RP; Little DM; Wright JT
    Prostaglandins Leukot Med; 1985 Aug; 19(2):115-22. PubMed ID: 3931098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets.
    Vincent JE; Zijlstra FJ; van Vliet H
    Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostaglandin precursors in platelet phosphoglycerides following acute myocardial infarction.
    Roshanai F; Sanders T; Howarth D; Haines A
    Thromb Res; 1981 Oct 1-15; 24(1-2):169-73. PubMed ID: 6277036
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of hydralazine on arachidonic acid metabolism in isolated, washed human platelets.
    Luderer JR; Demers LM; Janson RW; Nomides CT; Hayes AH
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):43-52. PubMed ID: 7394316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential fatty acids, prostaglandins, and respiratory distress syndrome of the newborn.
    Friedman Z; Demers LM
    Pediatrics; 1978 Mar; 61(3):341-7. PubMed ID: 643409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of three vasodilating agents as selective inhibitors of thromboxane A2 biosynthesis.
    Greenwald JE; Wong LK; Rao M; Bianchine JR; Panganamala RV
    Biochem Biophys Res Commun; 1978 Oct; 84(4):1112-8. PubMed ID: 728149
    [No Abstract]   [Full Text] [Related]  

  • 15. Separation of prostaglandins, thromboxane, hydroxy fatty acids and arachidonic acid by high pressure liquid chromatography.
    Eling T; Warnock R; Dick D; Tainer B
    Prostaglandins Med; 1980 Nov; 5(5):345-55. PubMed ID: 6779300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological relevance of the formation of 15-hydroxy derivative from dihomogammalinolenic acid in human platelets.
    Lagarde M; Naltchayan-Durbin S; Guichardant M; Mazet M; Dechavanne M
    Prog Clin Biol Res; 1987; 242():71-5. PubMed ID: 3671395
    [No Abstract]   [Full Text] [Related]  

  • 17. The identification of an epoxy-hydroxy acid as a product from the incubation of arachidonic acid with washed blood platelets.
    Walker IC; Jones RL; Wilson NH
    Prostaglandins; 1979 Aug; 18(2):173-8. PubMed ID: 523677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone decreases the formation of prostaglandins and related substances from arachidonic acid in rat vascular rings and human platelets.
    Oka M; Manku MS
    Prostaglandins Med; 1980 Mar; 4(3):193-203. PubMed ID: 7394062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ticlopidine on the aggregation of rat blood platelets and on the formation of metabolites from arachidonic acid and 8,11,14-eicosatrienoic acid in rat platelets during aggregation, and in the rat kidney.
    Vincent JE; Zijlstra FJ; vd Veerdonk MA; Bonta IL
    Agents Actions; 1982 Jul; 12(3):377-81. PubMed ID: 6814210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro platelet utilization of (1-14C) arachidonic acid in normal humans of different age and sex and in acute myocardial infarction patients: a comparative study for possible diagnostic purposes.
    Srivastava KC; Tiwari KP
    Prostaglandins Med; 1981 Sep; 7(3):229-43. PubMed ID: 6795653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.